Mark your calendars: on 17 July 2020, the Pharma and Life Science Day is taking place for the 7th time in Munich.
What to expect:
Participate in lively debates on best practice in patent and trademark protection
Get the latest updates on pharma case law from across the globe
Meet successful start-ups and learn from the strategy of big players
Get the real answers on protecting AI in Life Sciences - using patents or other strategies
Network with in-house counsels at an exclusive venue
What others say:
“I enjoyed it very much, not only the excellent lectures but meeting with known and not-yet-personally-known colleagues. I noted the next year date – I am striving to attend.”
“Many thanks again for the most enjoyable and informative IP event.”
“A day full of interesting presentations from Unfair Competition, Biosimilars and the Nagoya Protocal to Parallel Trade & the FMD.”
We are looking forward to seeing you in July during the Pharma and Life Science Day! Sign up for our newsletter here.
Back in November, Dr. Matthias Stolmár was invited to present his thoughts on the recent decision T1085/13 of the EPO's Boards of Appeal at the 2019 WIPF forum in the panel "Patent Challenges in the Pharma Industry". The talks and lively discussions have been recorded and broadcasted on HeTV and are now even available on Youtube.
On November 27 and 28, 2019, the event "Diagnostics-4-Future Conference"” will take place at the historic coucil on the shores of Lake Constance.
Stolmár & Partner will be represented by Dr. Matthias Stolmár. Stolmár & Partner is a law firm notable for competence i.a. in chemistry, life sciences, biotechnology, pharmacy, materials sciences and medical engineering located in Munich, Hamburg, Geneva and Tuttlingen. Stolmár & Partner provides patent services including the initial application of, defending, and attacking of existing patents. We also help with the enforcement of intellectual property rights such as patents, utility models, trademarks, designs, or Internet domains. Also, Stolmár & Partner supports clients in the design of license and cooperation agreements, as well as in the field of employee inventor’s law. The Firm has attorneys experienced and successful before the German Patent Office (DPMA), the European Patent Office (EPA) and the European Union Intellectual Property Office (EUIPO) as well as the French (INPI) and Swiss (IGE) Intellectual Property Office.
The event initiated by the international competence network for diagnostics 'DiagNET', coordinated by BioLAGO, the health network in the four-country of Lake Constance area (Germany, Switzerland, Austria and Liechtenstein), as well as co-organisers and partners such as Dr. Matthias Stolmár (http://www.stolmar-ip.com/), is addressed to companies, laboratories, clinics and doctors as well as research institutions in diagnostics and related fields such as medical technology, life science and pharmaceuticals. Last year, 160 experts from eight countries took part." The conference connects companies, physicians and research institutions for new diagnostic solutions. Leading experts from Europe report on the "hot" topics of the industry: cancer diagnostics, therapy-accompanying diagnostics, multi-resistant germs, lifestyle & diagnostics, artificial intelligence and digital diagnostics and much more.
Starting point are diagnostic questions of users (e.g. medical doctors, clinics, laboratories), which should give the impulse for new solutions by meeting with developers and technology suppliers. The event addresses also patient-oriented diagnostic solutions (point-of-care) to improve health care in rural areas. The conference will be accompanied by an exhibition and a poster award.
Among the speakers are Prof. Stephen Finn (St. James Hospital / University of Dublin, IRL), Dr. Yuksel Temiz (IBM Research, CH), Marlieke de Kraker (Geneva University Hospital, CH), Prof. Martin Widschwendter (University College London, UK), Dr. Françoise Wilhelmi de Toledo (Kliniken Buchinger Wilhelmi, DE) and Prof. Dr. Benedikt Brors (German Cancer Research Center DKFZ, DE).
We would be happy to welcome you to this event. Please do not hesitate to contact us for arrangements in advance: m.stolmar@stolmar-ip.com
The 70th Council Meeting of the Asian Patent Attorney Association (APAA) is scheduled for 9 to 12 November 2019 in Taipei, Taiwan with more than 1600 participants. Stolmár & Partner attends and will be represented by Dr. Matthias Stolmár.
APAA 2019 is intended to provide an opportunity for all participants to explore a wide range of IP hot topics presented in committee meetings, workshops, Country and WIPO reports and training courses focusing for example on Digital Piracy and Infringement, Best Practices for Design Filing, IP issues on social media advertising, Successful Licensing, Artificial Intelligence and Big Data.
We would be happy to meet you personally at this event. Please do not hesitate to contact us for arrangements in advance: m.stolmar@stolmar-ip.com.
Dr. Matthias Stolmár from Stolmár & Partner will present general aspects of employee inventor’s law and in particular of compensatory remuneration to members of the Licensing Executives Society Hungarian Group (LES Hungary) in Budapest on October 18, 2019.
An employee's invention is an invention made by an employee within the scope of his employment relationship and the employee's activity, which is regarded as patentable or utility modelable. In Germany, the employee is entitled to compensatory remuneration.
There are many pitfalls in the field of employees' inventions, especially for foreign companies having an R&D department in Germany. Dr Stolmár and his colleagues have extensive knowledge in this field and are happy to help you align your company's strategy with best practice.
Please do not hesitate to contact us for further information in this matter: m.stolmar@stolmar-ip.com
Stolmár & Partner, ARNOLD RUESS and Meyerlustenberger Lachenal are happy to invite you to our annual Pharma- and Life Sciences days on 12 July 2019 in the Suresnes Schlössl in Munich.
